Legislation: batch D — NY OH OK OR PA RI SC SD TX UT

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/ny/2023-2024/a-8501.md

@@ -0,0 +1,69 @@
+---
+type: "Bill"
+title: "Relates to adverse determinations related to a step therapy protocol override determination; repealer"
+description: "Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent."
+jurisdiction: "us/states/ny"
+legislature: "New York Legislature"
+session: "2023-2024"
+identifier: "A 8501"
+citation: "New York A 8501 (2023-2024)"
+classification: ["bill"]
+subjects: []
+status: "enacted"
+primary_sponsors: ["John T. McDonald III"]
+version_count: 1
+action_count: 12
+vote_count: 2
+first_action: "2024-01-04"
+last_action: "2024-02-07"
+source: "openstates"
+source_identifier: "ocd-bill/6f52e532-f632-4b4b-a786-82da86f298cd"
+source_url: "http://www.nysenate.gov/legislation/bills/2023/A8501"
+source_hash: "1da9360ffe1983e39547c53b9a4fe2fa2e7f8e716f9006e95820457f87d47ba9"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-ny"]
+---
+
+# New York A 8501 (2023-2024) — Relates to adverse determinations related to a step therapy protocol override determination; repealer
+
+Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **A8501** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=A8501&term=2023&Text=Y)
+
+## Votes
+
+- Floor Vote — **59–0** (pass) · upper
+- Assembly Vote — **139–2** (pass) · lower
+
+## Sponsors
+
+- John T. McDonald III — primary (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2024-01-04** REFERRED TO INSURANCE `referral-committee`
+- **2024-01-08** REPORTED
+- **2024-01-11** ADVANCED TO THIRD READING CAL.214
+- **2024-01-16** PASSED ASSEMBLY `passage`
+- **2024-01-16** DELIVERED TO SENATE
+- **2024-01-16** REFERRED TO RULES `referral-committee`
+- **2024-01-29** SUBSTITUTED FOR S8038
+- **2024-01-29** 3RD READING CAL.38
+- **2024-01-29** PASSED SENATE `passage`
+- **2024-01-29** RETURNED TO ASSEMBLY
+- **2024-02-07** DELIVERED TO GOVERNOR `executive-receipt`
+- **2024-02-07** SIGNED CHAP.28 `executive-signature`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/6f52e532-f632-4b4b-a786-82da86f298cd`. Confidence: reported (aggregated from official New York legislature records).
+